Taken together, these data suggest that transgenic expression of human ALOX15 under the control of the aP2 promoter does not protect from DSS-induced colitis as it was the case in the FCA paw edema model (Figs. 2, 3, 4, and 5). The gene discussed is ALOX15; the disease is colitis.